View Older Stories

May 19, 2026 06:01AM Relay Therapeutics reports positive data for vascular anomaly drug

Apr 29, 2026 07:06AM Relay Therapeutics (RLAY) PT Raised to $25 at H.C. Wainwright

Apr 28, 2026 05:24AM Relay Therapeutics (RLAY) PT Raised to $21 at Wells Fargo

Apr 28, 2026 04:12AM Relay Therapeutics (RLAY) PT Raised to $19 at Citizens -Triplet Update a 'Strong Positive'

Apr 27, 2026 04:30PM Relay Therapeutics (RLAY) PT Raised to $18 at Oppenheimer

Apr 27, 2026 10:51AM Relay Therapeutics (RLAY) PT Raised to $23 at Raymond James

Apr 27, 2026 06:00AM Relay announces plans for Phase 3 breast cancer trial of drug combination

Apr 23, 2026 10:21AM Relay Therapeutics (RLAY) PT Raised to $22 at Jefferies

Mar 23, 2026 06:46AM Relay Therapeutics (RLAY) PT Raised to $19 at H.C. Wainwright

Mar 20, 2026 09:48AM Raymond James on Relay (RLAY): ' ~60% upside to Relay’s current stock price, and we think with further derisking for a 1L breast cancer study that is conservative'

Mar 17, 2026 05:20AM Relay Therapeutics (RLAY) PT Raised to $17 at Citizens Following ESMO-TAT Update

Mar 16, 2026 04:37PM Oppenheimer reiterates Outperform on Relay Therapeutics (RLAY) as zovegalisib shows 11.1-month PFS

Mar 13, 2026 07:59AM Relay Therapeutics (RLAY) PT Raised to $22 at Guggenheim

Mar 3, 2026 05:08AM Relay Therapeutics (RLAY) Reiterated at Market Outperform by Citizens Before ESMO Congress

Feb 3, 2026 07:05AM Relay Therapeutics receives FDA breakthrough therapy designation for zovegalisib

Jan 26, 2026 06:03AM Oppenheimer Upgrades Relay Therapeutics (RLAY) to Outperform

Dec 12, 2025 07:01AM Relay Therapeutics reports subset analysis of breast cancer drug

Dec 12, 2025 05:08AM Wells Fargo Upgrades Relay Therapeutics (RLAY) to Overweight

Nov 18, 2025 04:45AM Relay Therapeutics' (RLAY) RLY-2608 An Interesting Opportunity - Citizens

Nov 6, 2025 04:53PM Relay Therapeutics, Inc. (RLAY) Misses Q3 EPS by 1c

Sep 4, 2025 05:40AM Guggenheim Starts Relay Therapeutics (RLAY) at Buy, New Best Idea

Aug 8, 2025 06:26AM Wells Fargo Reiterates Equal Weight Rating on Relay Therapeutics (RLAY)

Aug 7, 2025 05:21PM Relay Therapeutics, Inc. (RLAY) Tops Q2 EPS by 8c

Jun 11, 2025 04:07PM Relay Therapeutics (RLAY) appoints Claire Mazumdar to Board

Jun 3, 2025 04:27AM Citizens JMP Reiterates Market Outperform Rating on Relay Therapeutics (RLAY)

Jun 2, 2025 07:02AM Relay Therapeutics (RLAY) Announces Updated Data for RLY-2608 + Fulvestrant

May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025

May 5, 2025 04:10PM Relay Therapeutics, Inc. (RLAY) Tops Q1 EPS by 6c

Feb 28, 2025 04:26AM Relay Therapeutics (RLAY) PT Lowered to $12 at Citizens JMP

Feb 26, 2025 05:27PM Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c

Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview

Dec 12, 2024 06:02AM Relay Therapeutics (RLAY) PT Lowered to $20 at BofA Securities

Dec 4, 2024 06:48AM Relay Therapeutics (RLAY) PT Lowered to $16 at H.C. Wainwright

Dec 4, 2024 06:18AM Relay Therapeutics (RLAY) PT Lowered to $18 at Leerink Partners

Dec 3, 2024 08:01AM Relay Therapeutics (RLAY) and Elevar Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

Nov 6, 2024 04:44PM Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 14c

Oct 14, 2024 07:22AM H.C. Wainwright Reiterates Buy Rating on Relay Therapeutics (RLAY)

Oct 1, 2024 02:55PM Relay Therapeutics (RLAY) 17536 contracts of December 5 puts trade at 20c

Sep 16, 2024 06:55AM Relay Therapeutics (RLAY) PT Raised to $19 at H.C. Wainwright

Sep 16, 2024 06:45AM Stifel Reiterates Buy Rating on Relay Therapeutics (RLAY)

Sep 11, 2024 06:17AM Relay Therapeutics (RLAY) Prices 28.57M Share Offering at $7/sh

Sep 10, 2024 03:17AM Jefferies Upgrades Relay Therapeutics (RLAY) to Buy

Sep 10, 2024 02:20AM Oppenheimer Downgrades Relay Therapeutics (RLAY) to Perform

Sep 9, 2024 04:47PM Goldman Sachs Reinstates Relay Therapeutics (RLAY) at Buy

Sep 9, 2024 04:39PM After-hours movers: Oracle, Rubrik, Relay Therapeutics

Sep 9, 2024 04:34PM Relay Therapeutics (RLAY) Announces $200M Proposed Public Offering of Common Stock

Sep 9, 2024 03:20PM TD Cowen Out Positive on Relay Therapeutics (RLAY), Shares Up ~53%, 'we are constructive on Ph3 success based on today's data'

Sep 9, 2024 03:03PM Relay Therapeutics (RLAY) Shares Gain ~51%, PT Raised to $17 at Barclays

Sep 9, 2024 06:57AM Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Sep 4, 2024 10:00AM Relay Therapeutics (RLAY) PT Lowered to $20 at BofA Securities

View Older Stories